CYDEPS Dose Escalation Pain Study

CYDEPS – Dose escalation pain study 

The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential treatment for chronic back and/or neck pain.

The study is a single arm, open label clinical study which means everyone who participates will receive the experimental medication (there is no placebo).

The clinical study will run for approximately 5-6 weeks, and will include 8 study visits to a medical clinic over this time, each time seeing the study doctor. The clinical study is open to eligible participants in Sydney.



  • Be aged 18-75
  • Have a history of chronic neck and/or back pain for at least 3 months
  • Tried treatment with over the counter (OTC) treatments such as paracetamol and ibuprofen which haven’t worked



ACRN- Australian Clinical Research Network

Maroubra, NSW, Australia, 2035

Contact: Mark Arya (02) 83470645

Study Coordinator (02) 83470645


Holdsworth House Medical Practice

Sydney, NSW, Australia

Contact: Patient Recruitment Coordinator 

Email; PH: (02)803810

Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on email
Share on whatsapp

Medical Cannabis Information and Updates

Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world? We will send you informative information from time to time so you can learn about cannabis and if it can help you.